Journal of neuroscience researchHumansKetamineGlutamic AcidMaleFemale
Modulation of Magnetic Resonance Spectroscopy Levels of Glutamate and GABA by Ketamine in Treatment-Resistant Depression.
Stephanie Njau, Artemis Zavaliangos-Petropulu, Shantanu Joshi, John Brooks, Joseph O'Neill, Woods P Roger, Viviane Norris, Randall T Espinoza, Katherine L Narr
Published: 202610.1002/jnr.70102
Abstract
Ketamine has emerged as a highly effective intervention for treatment-resistant depression (TRD). Though it acts as a non-competitive antagonist of excitatory N-methyl-D-aspartate receptors (NMDAR), widely expressed in the brain, including on inhibit…
Preview only. Read the full abstract at the source